Deletions of chromosomes 3p and 14q molecularly subclassify clear cell renal cell carcinoma

作者：Kroeger Nils; Klatte Tobias; Chamie Karim; Rao P Nagesh; Birkhaeuser Frederic D; Sonn Geoffrey A; Riss Joseph; Kabbinavar Fairooz F; Belldegrun Arie S; Pantuck Allan J^*

来源：Cancer, 2013, 119(8): 1547-1554.

DOI：10.1002/cncr.27947

• renal cell carcinoma
• von Hippel-Lindau deletion
• hypoxia-inducible factor 1
• tumor suppressor gene
• cancer-specific survival
• recurrence-free survival

BACKGROUND: The short arm of chromosome 3 (3p) harbors the von Hippel-Lindau (VHL) tumor suppressor gene, and the long arm of chromosome 14 (14q) harbors the hypoxia-inducible factor 1 (HIF-1) gene. The objective of this study was to evaluate the significance of 3p loss (loss VHL gene) and 14q loss (loss HIF-1 gene) in clear cell renal cell carcinoma (ccRCC). METHODS: In total, 288 ccRCC tumors underwent a prospective cytogenetic analysis for alterations in chromosomes 3p and 14q. Tumors were assigned to 1 of 4 possible chromosomal alterations: VHL +3p/+14q (VHL wild type [VHL-WT]), VHL +3p/14q (VHL-WT plus HIF2 [WT/H2]), 3p/+14q (HIF1 and HIF2 [H1H2]), and 3p/14q (HIF2 [H2]). RESULTS: Among patients who had loss of 3p, tumors with 3p/14q (H2) alterations were larger (P = .002), had higher grade (P = .002) and stage (P = .001), and more often were metastatic (P = .029) than tumors that retained 14q (H1H2). All patients who had tumors with 3p/14q (H2) had worse cancer-specific survival (P = .014), and patients who had localized disease (P = .012) and primary T1 (pT1) tumors (P = .008) had worse recurrence-free survival. In patients who had pT1 tumors, combined 3p/14q loss was an independent predictor of recurrence-free survival (hazard ratio, 11.19; 95% confidence interval, 1.91-65.63) and cancer-specific survival (hazard ratio, 15.93; 95% confidence interval, 3.09-82.16). The current investigation was limited by its retrospective design, single-center experience, and a lack of confirmatory protein analyses. CONCLUSIONS: Loss of chromosome 3p (the VHL gene) was associated with improved survival in patients with ccRCC, whereas loss of chromosome 14q (the HIF-1 gene) was associated with worse outcomes. The results of the current study support the hypothesis that HIF-1 functions as an important tumor suppressor gene in ccRCC. Cancer 2013.

• 出版日期2013-4-15